In pancreatic and prostate cancers, TAZ/YAP activity has been implicated in tumour-promoting immune cell recruitment, due to TEAD-mediated expression of chemokines and cytokines [80,81,82]. The gene discussed is WWTR1; the disease is prostate carcinoma.